Botanical Safety Consortium Steering Committee
Cynthia Rider, PhD
Toxicologist, National Toxicology Program (NTP), National Institute of Environmental Health Sciences (NIEHS)
Cynthia serves as a project leader for testing programs including botanical dietary supplements. Her research focuses on evaluating and refining methods to predict mixture toxicity based on data from components or whole reference mixtures. She can be contacted at cynthia.rider@nih.gov
Cara Welch, PhD
Deputy Director, Office of Dietary Supplement Programs (ODSP), Center for Food Safety and Applied Nutrition, Food & Drug Administration (FDA)
Cara Welch leads the development of new policies and programs involving regulatory compliance and provides scientific expertise for emerging issues affecting the dietary supplement industry. She is also responsible for prioritization and execution of ODSP’s research portfolio. She can be contacted at cara.welch@fda.hhs.gov
Michelle Embry, PhD
Associate Director, Environmental Science, Health and Environmental Sciences Institute (HESI)
Michelle is the Associate Director of HESI, where she provides leadership, technical direction, and guidance to varied, multi-stakeholder, collaborative committees on topics related to risk assessment and environmental protection worldwide. She can be contacted at membry@hesiglobal.org
Bill J. Gurley, PhD
Professor and Principal Scientist at the National Center for Natural Products Research (NCNPR), School of Pharmacy, University of Mississippi
Dr. Gurley spent three decades conducting vital basic and clinical research on dietary supplement safety and efficacy. Notably, his research played a pivotal role in the FDA's removal of Ephedra-containing supplements from the U.S. market in 2004. Dr. Gurley was a trailblazer in assessing herb-drug interactions, notably shedding light on St. John's wort's clinical implications. His extensive work has culminated in 200+ peer-reviewed scientific publications. He contributes actively to the field as a member of the United States Pharmacopoeia's Expert Panel on Dietary Supplements and an advisor to the American Botanical Council. Dr. Gurley's editorial roles include sitting on the boards of Clinical Pharmacology & Therapeutics, Phytomedicine, HerbalGram, and Clinical Therapeutics. He holds degrees from Tennessee Technological University and the University of Tennessee Health Science Center.
Olaf Kelber, PhD
Senior Science Fellow, R&D Phytomedicines, Bayer Phytomedicines Supply and Development Center
Olaf is working as a scientist in R&D of phytomedicines and natural products. Biologist by training, with a specialization in toxicology, he has long standing experience also in pharmacology and clinical research on phytomedicines and is active in scientific societies in the field of natural products, and is e.g. secretary of the leading global society for natural product research, GA, and member of the scientific EWG of Kooperation Phytopharmaka. He can be contacted at olaf@kelber.org.
Julie Krzykwa, PhD
Scientific Program Manager, Health and Environmental Sciences Institute (HESI)
Julie works on the Botanical Safety Consortium and other scientific committees at HESI to develop science for a safer, more sustainable world. She can be contacted at jkrzykwa@hesiglobal.org.
Holly Johnson, PhD
Chief Science Officer, American Herbal Products Association
Holly has over 20 years experience in botanicals research as a pharmacognosist with a specialization in medical ethnobotany. She is the chief science officer for the American Herbal Products Association, an alliance of over 350 companies doing business in the natural products industry. She can be contacted at hjohnson@ahpa.org
Connie Mitchell, MS
Scientific Program Manager, Health and Environmental Sciences Institute (HESI)
Connie works on the Botanical Safety Consortium and other scientific committees at HESI to develop science for a safer, more sustainable world. She can be contacted at cmitchell@hesiglobal.org
Amy L Roe, PhD, DABT, FATS
Director Principal Toxicologist, Personal Health Care, The Proctor & Gamble Company
Amy is currently the technical lead regulatory toxicologist for P&G Personal Health Care, North America and Latin America Regions. She provides safety support across OTC drugs, medical devices, herbal/dietary supplements, probiotics and food products. She is a current member of the USP Dietary Supplement Admission Evaluation & Labeling Expert Committee and Probiotic Expert Panel. A Full Member of the Society of Toxicology, she current serves as Vice-President of the Food Safety Specialty Section. Amy is also a member of the Hepatotoxicity/ADME BSC working group.
Élan M. Sudberg, BA
CEO of Alkemist Labs
Élan M. Sudberg is CEO of Alkemist Labs, a passionately committed contract testing laboratory specializing in plant authentication, botanical ingredient identification and quantitative analytical services to the Food & Beverage, Nutraceutical and Cosmeceutical Industries. He holds a degree in chemistry from California State University Long Beach, and has authored numerous articles on phytochemistry and analytical techniques for the natural products and nutraceutical industry. Elan is on the executive committee of the AHPA board, on the AHPA Education and Research on Botanicals Foundation board, and was founding chair of the Hemp and Medical Marijuana committee (now the Cannabis Committee). He can be contacted at elan@alkemist.com